SCHEMBL7954751

SCHEMBL7954751

CNC(C)Nc1nc2c([N+](=O)[O-])cccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.49
PKN2 Q16513 1/20 0.49
ADORA3 P0DMS8 1/20 0.44
MGAM O43451 1/20 0.44
GAA P10253 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
RAB9A P51151 1/20 0.41
NPC1 O15118 1/20 0.40
PDE10A Q9Y233 1/20 0.39
COASY Q13057 1/20 0.39
NOS1 P29475 4/20 0.38
ALDH1A1 P00352 2/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
NOS2 P35228 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8601355 0.85 PKN1 (0.55) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7954749 0.79 PKN1 (0.49) PKN1PKN2ADORA3MGAMGAA
Dimethylamine SCHEMBL7486960 0.77 PKN1 (0.56) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7486053 0.77 PKN1 (0.50) PKN1PKN2ADORA3MGAMGAA
SCHEMBL1013853 0.77 LMNA (0.54) PKN1PKN2ADORA3MGAMGAA
SCHEMBL6543963 0.76 PKN1 (0.55) PKN1PKN2ADORA3MGAMGAA
SCHEMBL8328888 0.76 PKN1 (0.51) PKN1PKN2ADORA3MGAMGAA
SCHEMBL1013588 0.75 PKN1 (0.60) PKN1PKN2ADORA3MGAMGAA
SCHEMBL6513232 0.74 PKN1 (0.52) PKN1PKN2ADORA3MGAMGAA
SCHEMBL6511835 0.74 PKN1 (0.52) PKN1PKN2ADORA3MGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed